Preclinical Evaluation of Chicken Egg Yolk Antibody (IgY) Anti-RBD Spike SARS-CoV-2—A Candidate for Passive Immunization against COVID-19

The coronavirus disease 2019 (COVID-19) has become a substantial threat to the international health sector and the global economy. As of 26 December 2021, the number of mortalities resulting from COVID-19 exceeded 5.3 million worldwide. The absence of an effective non-vaccine treatment has prompted...

Descripción completa

Detalles Bibliográficos
Autores principales: Wongso, Hendris, Mahendra, Isa, Arnafia, Wyanda, Idar, Idar, Yusuf, Muhammad, Achmad, Arifudin, Holik, Holis A., Kurniawan, Ahmad, Halimah, Iim, Sriyani, Maula E., Wibawa, Teguh H. A., Febrian, Muhamad B., Setiadi, Yanuar, Widyasari, Eva M., Daruwati, Isti, Kusumaningrum, Crhisterra E., Subroto, Toto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778912/
https://www.ncbi.nlm.nih.gov/pubmed/35062789
http://dx.doi.org/10.3390/vaccines10010128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778912/
https://www.ncbi.nlm.nih.gov/pubmed/35062789
http://dx.doi.org/10.3390/vaccines10010128

Ejemplares similares